Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in diagnostic testing.

P E Verweij1

  • 1Department of Medical Microbiology, University Medical Centre Nijmegen, Nijmegen, The Netherlands. p.verweij@mmb.umcn.nl

Medical Mycology
|August 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One health and resistant fungi: a challenging balancing act between food security and patient survival.

Expert review of anti-infective therapy·2026
Same author

Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands.

Scientific reports·2023
Same author

Corrigendum to "How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates" [Clin Microbiol Infect 25 (2019) 681-687].

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2023
Same author

Liposomal amphotericin B-the future.

The Journal of antimicrobial chemotherapy·2022
Same author

Regional Differences in Antifungal Susceptibility of the Prevalent Dermatophyte Trichophyton rubrum.

Mycopathologia·2020
Same author

<i>Aspergillus fumigatus</i>-specific antibodies in patients with chronic tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same journal

Diagnostic performance of IgG against multiplex Aspergillus antigens (mx4) for identifying chronic pulmonary aspergillosis.

Medical mycology·2026
Same journal

The clinical utility of bronchoalveolar lavage galactomannan result stewardship within a tertiary medical system.

Medical mycology·2026
Same journal

Cross-reactivity of Cryptococcal Antigen Lateral Flow Assay with Basidiomycetous Yeasts.

Medical mycology·2026
Same journal

Cryptococcus gattii complex infections in southern Brazil: epidemiology, clinical features, management and outcomes from a 33-year cohort.

Medical mycology·2026
Same journal

HAC1 contributes to stress adaptation and virulence in the emerging fungal pathogen Candida auris.

Medical mycology·2026
Same journal

Multicenter Study Reveals Alarming Terbinafine Resistance in Trichophyton indotineae Isolates from Iran.

Medical mycology·2026
See all related articles

Early diagnosis of invasive aspergillosis is improved by surrogate markers like galactomannan and beta-D-glucan. Further research is needed to understand marker kinetics and optimize diagnostic strategies.

Area of Science:

  • Mycology
  • Clinical Diagnostics
  • Infectious Diseases

Background:

  • Surrogate markers are crucial for early invasive aspergillosis diagnosis.
  • Commercial assays exist for galactomannan and (1 --> 3)-beta-D-glucan antigens.
  • Experimental PCR assays for fungal DNA have been developed.

Purpose of the Study:

  • To investigate the kinetics of surrogate markers for invasive aspergillosis.
  • To understand factors influencing assay performance, such as antifungal exposure and cut-off levels.
  • To optimize diagnostic management strategies and test sequencing.

Main Methods:

  • Review of recent clinical validation studies on surrogate markers.
  • Analysis of variables affecting assay performance (antifungal agents, cut-off levels).

Related Experiment Videos

  • Exploration of marker kinetics in relation to invasive aspergillosis.

    • Main Results:

    • Kinetics of surrogate markers remain largely unknown despite numerous validation studies.
    • Assay performance is influenced by factors like antifungal exposure and interpretive cut-offs.
    • Understanding these variables is key to improving diagnostic accuracy.

    Conclusions:

    • Surrogate markers are valuable tools for early invasive aspergillosis detection.
    • Further research into marker kinetics and influencing factors is essential.
    • Optimized management and test sequencing will enhance patient outcomes.